Displaying 500 actively recruiting clinical trials nationwide

Study Name Sponsor Status Trial Phase Quota Distance
Phase 2b Study to Evaluate the Efficacy and Safety of GBR 830 in Adults With Moderate to Severe Atopic Dermatitis Glenmark Pharmaceuticals S.A. Recruiting
2
Trial Phase
392
Trial Size
2.25 2 miles
An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus Genentech, Inc. Recruiting
2
Trial Phase
240
Trial Size
3.14 3 miles
Connect® MM- The Multiple Myeloma Disease Registry Celgene Corporation Recruiting N/A
3000
Trial Size
3.50 4 miles
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits in Subjects Who Participated in the DALF-PS-1016 Study Acorda Therapeutics Recruiting
3
Trial Phase
100
Trial Size
3.50 4 miles
The Effect of Vertical Versus Horizontal Vaginal Cuff Closure on Vaginal Length After Laparoscopic Hysterectomy Bridgeport Hospital Recruiting N/A
50
Trial Size
4.37 4 miles
Automated Bilingual Computerized Alcohol Screening and Intervention in Latinos (AB-CASI) Yale University Recruiting N/A
820
Trial Size
4.37 4 miles
A Pancreatic Cancer Screening Study in Individuals With New-Onset Diabetes Mellitus Western Connecticut Health Network Recruiting N/A
800
Trial Size
11.54 12 miles
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Southwest Oncology Group Recruiting
3
Trial Phase
1900
Trial Size
12.45 12 miles
"Efficacy of Botulinum Toxin Injection in Reducing Limb Pain in Patients With Complex Regional Pain Syndrome" VA Connecticut Healthcare System Recruiting
1
Trial Phase
20
Trial Size
12.85 13 miles
Prometra Post-Approval Study Flowonix Medical Recruiting N/A
400
Trial Size
14.44 14 miles
Intravenous (IV) Nicotine Self Administration: Dose Ranging and Sex Differences in Smokers Yale University Recruiting N/A
64
Trial Size
15.46 15 miles
Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence Yale University Recruiting
2
Trial Phase
30
Trial Size
15.46 15 miles
Oxygen Versus PAP for Treatment of Sleep Apnea in Chronic Heart Failure Department of Veterans Affairs Recruiting
4
Trial Phase
161
Trial Size
15.46 15 miles
Sensitivity to Intravenous Nicotine: Genetic Moderators Yale University Recruiting
1
Trial Phase
300
Trial Size
15.46 15 miles
Effects of Psilocybin in Post-Traumatic Headache Yale University Recruiting
2
Trial Phase
24
Trial Size
15.46 15 miles
Safety and Efficacy of Adjunctive Pimavanserin in Adults With Parkinson's Disease and Inadequately Controlled Depression ACADIA Pharmaceuticals Inc. Recruiting
2
Trial Phase
65
Trial Size
15.89 16 miles
Phase 3 Efficacy Study of AGN-190584 in Participants With Presbyopia Allergan Recruiting
3
Trial Phase
300
Trial Size
15.89 16 miles
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Duke University Recruiting N/A
3000
Trial Size
15.96 16 miles
A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation Astellas Pharma Inc Recruiting
3
Trial Phase
369
Trial Size
15.96 16 miles
Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures Yale University Recruiting
4
Trial Phase
100
Trial Size
16.59 17 miles
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma Bristol-Myers Squibb Available N/A
0
Trial Size
17.18 17 miles
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE) Edwards Lifesciences Recruiting N/A
1025
Trial Size
17.18 17 miles
Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 13C-MRS Yale University Recruiting
1
Trial Phase
30
Trial Size
17.18 17 miles
Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET Yale University Recruiting N/A
48
Trial Size
17.18 17 miles
GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration Yale University Recruiting
1
Trial Phase
24
Trial Size
17.18 17 miles
The Effect of Dietary Salt Intake on Immune Function in Patients With Multiple Sclerosis Yale University Recruiting N/A
25
Trial Size
17.18 17 miles
Naltrexone and Memantine Effects on Alcohol Drinking Behaviors Yale University Recruiting
2
Trial Phase
86
Trial Size
17.18 17 miles
Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors Yale University Recruiting
1
Trial Phase
97
Trial Size
17.18 17 miles
Flavors and E-cigarette Effects in Adolescent Smokers Yale University Recruiting
1
Trial Phase
60
Trial Size
17.18 17 miles
The Human Microbiome in Immune-Mediated Diseases Yale University Recruiting N/A
90
Trial Size
17.18 17 miles
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome Allergan Recruiting
2
Trial Phase
116
Trial Size
17.18 17 miles
Safety Evaluation of Repeat Placement of the S8 Sinus Implant in Chronic Sinusitis Patients With Nasal Polyps (ENCORE) Intersect ENT Recruiting
3
Trial Phase
50
Trial Size
17.18 17 miles
Imaging mGluR5 and Synaptic Density in Psychiatric Disorders Yale University Recruiting N/A
90
Trial Size
17.18 17 miles
Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita Palvella Therapeutics, Inc. Recruiting
2
Trial Phase
60
Trial Size
17.18 17 miles
The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders Yale University Recruiting
1
Trial Phase
60
Trial Size
17.18 17 miles
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH) Teva Pharmaceutical Industries Recruiting
3
Trial Phase
300
Trial Size
17.73 18 miles
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease Eli Lilly and Company Recruiting
2
Trial Phase
285
Trial Size
17.73 18 miles
Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes Yale University Recruiting
0
Trial Phase
30
Trial Size
17.88 18 miles
Safety and Tolerability of Metronidazole Gel 1.3% Watson Pharmaceuticals Recruiting
4
Trial Phase
60
Trial Size
17.88 18 miles
Mindfulness Based Stress Reduction for Metabolic Syndrome Yale University Recruiting N/A
40
Trial Size
17.88 18 miles
A Phase I Study of BTRC4017A in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers Genentech, Inc. Recruiting
1
Trial Phase
449
Trial Size
17.88 18 miles
Galantamine and CBT4CBT Pilot Yale University Recruiting
1
Trial Phase
30
Trial Size
17.88 18 miles
Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements Pfizer Recruiting
1
Trial Phase
32
Trial Size
17.88 18 miles
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer Taiho Oncology, Inc. Available N/A
0
Trial Size
17.91 18 miles
SURPASS: A Randomized, Double-Blind, Multicenter Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus (CMV) Disease in CMV Seropositive Kidney Transplant Recipients (BCV CMV vGCV) Chimerix Recruiting
3
Trial Phase
520
Trial Size
17.91 18 miles
SUSTAIN: A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV Seronegative Kidney Allograft Recipients Chimerix Recruiting
3
Trial Phase
750
Trial Size
17.91 18 miles
Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes Medtronic Diabetes Recruiting
3
Trial Phase
150
Trial Size
17.91 18 miles
The Effects of a Moderate Weight Loss on Insulin Resistance Yale University Recruiting N/A
35
Trial Size
17.91 18 miles
Basic Research Study to Examine the Relation Between Muscle Insulin Resistance and Lipid Production in the Liver. Yale University Recruiting N/A
80
Trial Size
17.91 18 miles
Pilot Study for Verifying Endotracheal Tube Repositioning Using Ultrasound Yale University Recruiting N/A
25
Trial Size
17.91 18 miles
Neurofeedback for Tourette Syndrome Yale University Recruiting N/A
30
Trial Size
17.91 18 miles
A Phase 1b/2 Study of OMP-59R5 in Combination With Etoposide and Platinum Therapy in Subjects With Untreated Extensive Stage Small Cell Lung Cancer (PINNACLE) OncoMed Pharmaceuticals, Inc. Recruiting
1
Trial Phase
80
Trial Size
17.91 18 miles
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry Monteris Medical Recruiting N/A
300
Trial Size
17.91 18 miles
A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma Ann & Robert H Lurie Children's Hospital of Chicago Recruiting
3
Trial Phase
160
Trial Size
17.91 18 miles
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint Agendia Recruiting N/A
1200
Trial Size
17.91 18 miles
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia National Cancer Institute (NCI) Recruiting
3
Trial Phase
4895
Trial Size
17.91 18 miles
Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa Dana-Farber Cancer Institute Recruiting
2
Trial Phase
170
Trial Size
17.91 18 miles
Heart And Lung Failure - Pediatric INsulin Titration Trial Children's Hospital Boston Recruiting
3
Trial Phase
1414
Trial Size
17.91 18 miles
Linking Former Inmates to Primary Care Yale University Recruiting N/A
2000
Trial Size
17.91 18 miles
Perioperative Blood Pressures and Chronic Hypertension Yale University Recruiting N/A
200
Trial Size
17.91 18 miles
Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders Yale University Recruiting N/A
40
Trial Size
17.91 18 miles
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma Northwestern University Recruiting
2
Trial Phase
35
Trial Size
17.91 18 miles
CD40 Agonistic Antibody APX005M in Combination With Nivolumab Apexigen, Inc. Recruiting
1
Trial Phase
99
Trial Size
17.91 18 miles
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor Sera Prognostics, Inc. Recruiting N/A
4000
Trial Size
17.91 18 miles
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma [IMbrave150] Hoffmann-La Roche Recruiting
3
Trial Phase
480
Trial Size
17.91 18 miles
Human Epilepsy Project 2: Resistant Focal Seizures Study Epilepsy Foundation of America Recruiting N/A
205
Trial Size
17.91 18 miles
Patient and Parent Preferences for an On-Body Automated Insulin Delivery System Joslin Diabetes Center Recruiting N/A
200
Trial Size
17.91 18 miles
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors Johns Hopkins University Recruiting N/A
1000
Trial Size
17.91 18 miles
The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTA Yale University Recruiting
1
Trial Phase
12
Trial Size
17.91 18 miles
Computer Based Training in Cognitive Behavioral Therapy Web-based Yale University Recruiting
1
Trial Phase
180
Trial Size
18.06 18 miles
Corticosteroid Dosage for Crohn's Disease Flare Yale University Recruiting
4
Trial Phase
182
Trial Size
18.06 18 miles
Evaluation of the Duration of Therapy for Thrombosis in Children University of Colorado, Denver Recruiting
3
Trial Phase
750
Trial Size
18.06 18 miles
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System Monteris Medical Recruiting N/A
1000
Trial Size
18.06 18 miles
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults City of Hope Medical Center Recruiting N/A
700
Trial Size
18.06 18 miles
New Haven MOMS Partnership Yale University Recruiting N/A
160
Trial Size
18.06 18 miles
MOMS Hubs- CT Dept of Social Services Block Grant Yale University Recruiting N/A
120
Trial Size
18.06 18 miles
A Study of Symptoms and Quality of Life in Patients With Implantable Cardiac Defibrillators (ICDs) and Their Caregivers Mount Sinai School of Medicine Recruiting N/A
1200
Trial Size
18.06 18 miles
An Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation Conversations Mount Sinai School of Medicine Recruiting N/A
1200
Trial Size
18.06 18 miles
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738) Merck Recruiting
2
Trial Phase
1960
Trial Size
18.06 18 miles
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma Associazione Angela Serra per la ricerca sul cancro Recruiting N/A
2000
Trial Size
18.06 18 miles
Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer. Yale University Recruiting
2
Trial Phase
50
Trial Size
18.06 18 miles
Post-Market Surveillance With a Novel mHealth Platform Yale University Recruiting N/A
60
Trial Size
18.06 18 miles
Assessment of the Biodistribution and Safety of [18F]MNI-958 in Healthy Subjects Invicro Recruiting
1
Trial Phase
6
Trial Size
18.06 18 miles
A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes Yale University Recruiting
1
Trial Phase
15
Trial Size
18.06 18 miles
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors Genmab Recruiting
1
Trial Phase
188
Trial Size
18.06 18 miles
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease Otonomy, Inc. Recruiting
3
Trial Phase
160
Trial Size
18.06 18 miles
Bariatric Scalable Internet Treatments Yale University Recruiting N/A
52
Trial Size
18.06 18 miles
Validating Imaging Biomarkers of Small Vessel Disease in Diabetic Individuals Using Advanced MRI Techniques. Yale University Recruiting N/A
50
Trial Size
18.06 18 miles
Comparing an Inexpensive Handheld Ultrasound Machine and a Large Mobile Ultrasound System Yale University Recruiting N/A
75
Trial Size
18.06 18 miles
Immunologic Mechanisms in Neurological Diseases Yale University Recruiting N/A
800
Trial Size
18.06 18 miles
The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms Yale University Recruiting
1
Trial Phase
40
Trial Size
18.06 18 miles
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer Kymab Limited Recruiting
1
Trial Phase
412
Trial Size
18.06 18 miles
A Phase 1 Clinical Trial of ARV-110 in Patients With Metastatic Castration-resistant Prostate Cancer. Arvinas Inc Recruiting
1
Trial Phase
36
Trial Size
18.06 18 miles
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment Yale University Recruiting
3
Trial Phase
180
Trial Size
18.06 18 miles
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment Yale University Recruiting
3
Trial Phase
80
Trial Size
18.06 18 miles
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders Yale University Recruiting
2
Trial Phase
40
Trial Size
18.06 18 miles
SV2 PET Imaging With [11C]APP311 Yale University Recruiting N/A
120
Trial Size
18.06 18 miles
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer Halozyme Therapeutics Recruiting
2
Trial Phase
237
Trial Size
18.90 19 miles
Stamford Group Family Nurture Intervention Columbia University Recruiting N/A
160
Trial Size
18.90 19 miles
Children's Learning Centers Group FNI Columbia University Recruiting N/A
280
Trial Size
18.90 19 miles
Expanded Access Program With Nivolumab to Treat Melanoma Bristol-Myers Squibb Available N/A
0
Trial Size
21.01 21 miles
Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy Pfizer Available
4
Trial Phase
0
Trial Size
21.01 21 miles
Safety, Tolerability, PK and Antitumor Activity of KPG-121 Plus Enzalutamide in mCRPC Patients Kangpu Biopharmaceuticals, Ltd. Recruiting
1
Trial Phase
24
Trial Size
21.01 21 miles
Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology Stony Brook University Recruiting
4
Trial Phase
144
Trial Size
21.01 21 miles
Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Metastatic TNBC and Tesetaxel Monotherapy in Patients With HER2 Negative MBC Odonate Therapeutics, Inc. Recruiting
2
Trial Phase
130
Trial Size
21.01 21 miles
A Multicenter, 2 Part Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Rheumatoid Arthritis Mallinckrodt Recruiting
4
Trial Phase
232
Trial Size
22.53 23 miles
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma National Cancer Institute (NCI) Recruiting
2
Trial Phase
160
Trial Size
22.68 23 miles
Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections The Medicines Company Recruiting
1
Trial Phase
60
Trial Size
22.68 23 miles
A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns MediWound Ltd Recruiting
3
Trial Phase
175
Trial Size
22.68 23 miles
Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women Harvard School of Public Health Recruiting N/A
3400
Trial Size
22.68 23 miles
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure Duke University Recruiting
2
Trial Phase
360
Trial Size
22.68 23 miles
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 Northwest Biotherapeutics Available N/A
0
Trial Size
22.68 23 miles
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients PLC Medical Systems, Inc. Recruiting
3
Trial Phase
326
Trial Size
22.68 23 miles
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO) Pharmacyclics LLC. Recruiting
3
Trial Phase
287
Trial Size
22.68 23 miles
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma Exact Sciences Corporation Recruiting N/A
1500
Trial Size
22.68 23 miles
CD4CAR for CD4+ Leukemia and Lymphoma Stony Brook University Recruiting
1
Trial Phase
20
Trial Size
22.68 23 miles
EKG Criteria and Identification of Acute Coronary Occlusion Stony Brook University Recruiting N/A
2000
Trial Size
22.68 23 miles
POSITIVE Stroke Clinical Trial Medical University of South Carolina Recruiting N/A
750
Trial Size
23.10 23 miles
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia National Cancer Institute (NCI) Recruiting
1
Trial Phase
54
Trial Size
23.14 23 miles
Ivabradine for Rate Control in Permanent Atrial Fibrillation Yale University Recruiting
1
Trial Phase
15
Trial Size
23.99 24 miles
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Eli Lilly and Company Recruiting
3
Trial Phase
1800
Trial Size
25.04 25 miles
18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain Memorial Sloan-Kettering Cancer Center Recruiting N/A
20
Trial Size
26.08 26 miles
Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients Memorial Sloan-Kettering Cancer Center Recruiting N/A
150
Trial Size
26.08 26 miles
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations Memorial Sloan-Kettering Cancer Center Recruiting N/A
320
Trial Size
26.08 26 miles
Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life Memorial Sloan-Kettering Cancer Center Recruiting N/A
200
Trial Size
26.08 26 miles
Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies Memorial Sloan-Kettering Cancer Center Recruiting N/A
12
Trial Size
26.08 26 miles
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma Memorial Sloan-Kettering Cancer Center Recruiting N/A
3000
Trial Size
26.08 26 miles
Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma Memorial Sloan-Kettering Cancer Center Recruiting N/A
29
Trial Size
26.08 26 miles
Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM) Memorial Sloan-Kettering Cancer Center Recruiting
1
Trial Phase
24
Trial Size
26.08 26 miles
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Dana-Farber Cancer Institute Recruiting
2
Trial Phase
500
Trial Size
26.08 26 miles
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) Memorial Sloan-Kettering Cancer Center Recruiting
2
Trial Phase
86
Trial Size
26.08 26 miles
Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management Memorial Sloan-Kettering Cancer Center Recruiting
1
Trial Phase
24
Trial Size
26.08 26 miles
Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
57
Trial Size
26.08 26 miles
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control Memorial Sloan Kettering Cancer Center Recruiting
3
Trial Phase
140
Trial Size
26.08 26 miles
Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations Memorial Sloan Kettering Cancer Center Recruiting N/A
195
Trial Size
26.08 26 miles
Easing Psychosocial Burden for Informal Caregivers Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
70
Trial Size
26.08 26 miles
Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
26
Trial Size
26.08 26 miles
Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
16
Trial Size
26.08 26 miles
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job Memorial Sloan Kettering Cancer Center Recruiting N/A
450
Trial Size
26.08 26 miles
Ixazomib Maintenance Study in Patients With AL Amyloidosis Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
47
Trial Size
26.08 26 miles
Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
25
Trial Size
26.08 26 miles
A Quality of Life Study in Patients Undergoing Percutaneous Biliary Drainage Memorial Sloan Kettering Cancer Center Recruiting N/A
125
Trial Size
26.08 26 miles
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
60
Trial Size
26.08 26 miles
A Study of Dacomitinib in Patients With Metastatic EGFR Mutant Lung Cancer Previously Treated With Osimertinib Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
24
Trial Size
26.08 26 miles
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
142
Trial Size
26.08 26 miles
Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Cancers of the Breast and Lung Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
160
Trial Size
26.08 26 miles
A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
45
Trial Size
26.08 26 miles
Healthy Marriage and Responsible Fatherhood Grant Program With Phoenix House of New York Phoenix House Foundation, Inc. Recruiting N/A
3825
Trial Size
27.83 28 miles
The Role of Emotional Arousal in Food Preference and Taste Yale University Recruiting N/A
150
Trial Size
28.27 28 miles
Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics Memorial Sloan-Kettering Cancer Center Recruiting N/A
30
Trial Size
28.56 29 miles
Effect of Autologous Blood Patch Injection Versus BioSentry Hydrogel Tract Plug in the Reduction of Pneumothorax Risk Following Lung Biopsy Procedures Memorial Sloan-Kettering Cancer Center Recruiting
3
Trial Phase
600
Trial Size
28.56 29 miles
Treating Patients With Melanoma and ALK Alterations With Ensartinib Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
18
Trial Size
28.56 29 miles
A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula Allergan Recruiting
4
Trial Phase
75
Trial Size
28.56 29 miles
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas Memorial Sloan Kettering Cancer Center Recruiting N/A
150
Trial Size
28.56 29 miles
A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
45
Trial Size
28.56 29 miles
Artisan Aphakia Lens for the Correction of Aphakia (Secondary) in Adults Ophtec USA Recruiting
3
Trial Phase
300
Trial Size
28.73 29 miles
Artisan Aphakia Lens for the Correction of Aphakia in Children Ophtec USA Recruiting
3
Trial Phase
300
Trial Size
28.73 29 miles
Virtual Reality and Active Video Games to Improve Balance in Children With Brain Injury Blythedale Children's Hospital Recruiting N/A
10
Trial Size
28.73 29 miles
Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis Proteostasis Therapeutics, Inc. Recruiting
2
Trial Phase
40
Trial Size
28.73 29 miles
Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome New York Medical College Recruiting
2
Trial Phase
20
Trial Size
28.73 29 miles
A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH (Aramcho Galmed Pharmaceuticals Ltd Recruiting
2
Trial Phase
240
Trial Size
29.42 29 miles
Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis Taro Pharmaceuticals USA Recruiting
4
Trial Phase
100
Trial Size
29.42 29 miles
Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008 Pfizer Available N/A
0
Trial Size
29.42 29 miles
Adaptive Interventions for Minimally Verbal Children With ASD in the Community Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting N/A
192
Trial Size
29.57 30 miles
Benfotiamine in Alzheimer's Disease: A Pilot Study Burke Medical Research Institute Recruiting
2
Trial Phase
76
Trial Size
29.57 30 miles
Non-Invasive Stimulation for Improving Motor Function Burke Medical Research Institute Recruiting
2
Trial Phase
30
Trial Size
29.57 30 miles
Can Cognitive Training Decrease Reactive Aggression? Weill Medical College of Cornell University Recruiting N/A
90
Trial Size
29.57 30 miles
A Trial of BXCL701 and Pembrolizumab in Patients With Small Cell Neuroendocrine Prostate Cancer BioXcel Therapeutics Inc Recruiting
1
Trial Phase
40
Trial Size
29.66 30 miles
Sleep Health Literacy in Head Start Albert Einstein College of Medicine, Inc. Recruiting N/A
540
Trial Size
29.72 30 miles
To Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer in Primary Unilateral Total Knee Arthroplasty Northwell Health Recruiting N/A
168
Trial Size
30.72 31 miles
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) ImmusanT, Inc. Recruiting
2
Trial Phase
146
Trial Size
31.95 32 miles
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies Novartis Recruiting N/A
3600
Trial Size
32.24 32 miles
Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine Cady, Roger, M.D. Recruiting
2
Trial Phase
45
Trial Size
32.24 32 miles
Post Market Clinical Follow Up Study for ReliaTack™ Articulating Reloadable Fixation Device With Deep Purchase Tacks Medtronic - MITG Recruiting N/A
116
Trial Size
32.86 33 miles
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain New York Institute of Technology Recruiting N/A
48
Trial Size
34.89 35 miles
Palpatory and Ultrasound Assessment of Cervical Dysfunctions and the Effect of Cervical High Velocity Low Amplitude (HVLA) Technique New York Institute of Technology Recruiting N/A
52
Trial Size
34.89 35 miles
Effect of Osteopathic Manipulative Medicine on Motor Function and Quality of Life in Cervical Dystonia New York Institute of Technology Recruiting N/A
50
Trial Size
34.89 35 miles
Assessing the Efficacy of Smartphone Calorie Calculator Application on Body Composition With and Without Intervention New York Institute of Technology Recruiting N/A
20
Trial Size
34.89 35 miles
Impact of Individual Cognitive Remediation for Parkinson's Disease New York Institute of Technology Recruiting N/A
20
Trial Size
34.89 35 miles
Lifestyle Intervention Program in Overweight Medical Students New York Institute of Technology Recruiting N/A
40
Trial Size
34.89 35 miles
A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer. University College London Hospitals Recruiting N/A
1796
Trial Size
34.95 35 miles
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension Allergan Recruiting
3
Trial Phase
600
Trial Size
35.28 35 miles
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia Pharmacyclics Recruiting N/A
1500
Trial Size
35.29 35 miles
Orthosensor vs Conventional Total Knee Arthroplasty Columbia University Recruiting N/A
130
Trial Size
35.76 36 miles
Obalon Post-Approval Study Obalon Therapeutics, Inc. Recruiting N/A
200
Trial Size
36.15 36 miles
AR-Power Patient Powered Research Network Global Healthy Living Foundation Recruiting N/A
9867
Trial Size
36.35 36 miles
The Role of HMGB-1 in Chronic Stroke North Shore Long Island Jewish Health System Recruiting N/A
100
Trial Size
36.81 37 miles
Robots Paired With tDCS in Stroke Recovery North Shore Long Island Jewish Health System Recruiting
2
Trial Phase
66
Trial Size
36.81 37 miles
The General Use of Robots in Stroke Recovery: the Anklebot North Shore Long Island Jewish Health System Recruiting N/A
55
Trial Size
36.81 37 miles
Prospective Evaluation of Residual Bile Duct Stone by Peroral Cholangioscopy After Conventional ERCP Northwell Health Recruiting N/A
140
Trial Size
36.81 37 miles
Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke Northwell Health Recruiting
2
Trial Phase
35
Trial Size
36.81 37 miles
Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System Northwell Health Recruiting N/A
3
Trial Size
36.81 37 miles
PoNS Clinical Experience Program (TBI) Neurohabilitation Corporation Recruiting N/A
20
Trial Size
36.81 37 miles
The Use of Trifluoperazine in Transfusion Dependent DBA Northwell Health Recruiting
1
Trial Phase
24
Trial Size
36.81 37 miles
The Effects of Nicotine Chewing Gum in Parkinson's Disease New York Institute of Technology Recruiting
1
Trial Phase
10
Trial Size
36.96 37 miles
Whole Body Periodic Acceleration on Blood Lactate and Recovery New York Institute of Technology Recruiting
0
Trial Phase
10
Trial Size
36.96 37 miles
: A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men ( TRAVERSE ) AbbVie Recruiting
4
Trial Phase
6000
Trial Size
36.96 37 miles
Metformin Prostate Cancer Adjuvant Trial Winthrop University Hospital Recruiting
2
Trial Phase
70
Trial Size
38.36 38 miles
Differential Characteristics of Neuropathy in Type 2 Diabetics With and Without Lower Extremity Wounds Winthrop University Hospital Recruiting N/A
30
Trial Size
38.36 38 miles
Cutaneous and Systemic Reactions to Metal Implants Winthrop University Hospital Recruiting N/A
100
Trial Size
38.36 38 miles
Phase 2 Study of an Immunotherapeutic Treatment, DPX-Survivac in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors ImmunoVaccine Technologies, Inc. (IMV Inc.) Recruiting
2
Trial Phase
232
Trial Size
38.36 38 miles
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects HumanOptics AG Recruiting
3
Trial Phase
460
Trial Size
38.40 38 miles
A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy Braintree Laboratories Recruiting
3
Trial Phase
575
Trial Size
38.40 38 miles
Safety & Efficacy Evaluation of a Radiofrequency & Laser/Light System for Improvement of Skin Texture Candela Corporation Recruiting N/A
150
Trial Size
38.72 39 miles
A Clinical Trial for the Surgical Treatment of Elderly Distal Radius Fractures University of Michigan Recruiting
3
Trial Phase
623
Trial Size
38.72 39 miles
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC) Genentech, Inc. Recruiting
2
Trial Phase
270
Trial Size
38.72 39 miles
Effect of Nusinersen on Adults With Spinal Muscular Atrophy Northwell Health Recruiting N/A
40
Trial Size
38.72 39 miles
Control of Myopia Using Novel Spectacle Lens Designs SightGlass Vision, Inc. Recruiting N/A
255
Trial Size
39.21 39 miles
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas North Shore Long Island Jewish Health System Recruiting
1
Trial Phase
36
Trial Size
39.42 39 miles
Expanded Access and Open Label Extension Study of SER-109 to Prevent Recurrent Clostridium Difficile Infection Seres Health Inc Available
2
Trial Phase
29
Trial Size
39.42 39 miles
Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis North Shore Long Island Jewish Health System Recruiting
2
Trial Phase
100
Trial Size
39.42 39 miles
Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis Corbus Pharmaceuticals Inc. Recruiting
2
Trial Phase
415
Trial Size
39.42 39 miles
Quality of Life in Patients With Congenital Afibrinogenemia University Hospital, Geneva Recruiting N/A
150
Trial Size
39.42 39 miles
Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease ACADIA Pharmaceuticals Inc. Recruiting
3
Trial Phase
300
Trial Size
39.42 39 miles
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG) North Shore Long Island Jewish Health System Recruiting
1
Trial Phase
6
Trial Size
39.43 39 miles
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi Novartis Recruiting
3
Trial Phase
420
Trial Size
39.43 39 miles
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds Arteriocyte, Inc. Recruiting N/A
1500
Trial Size
39.43 39 miles
Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate Pfizer Available
3
Trial Phase
0
Trial Size
39.43 39 miles
A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease Hoffmann-La Roche Recruiting
1
Trial Phase
12
Trial Size
39.43 39 miles
A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia BeiGene Recruiting
3
Trial Phase
400
Trial Size
39.43 39 miles
Study of Zanubrutinib (BGB-3111) in Patients With Marginal Zone Lymphoma BeiGene Recruiting
2
Trial Phase
65
Trial Size
39.43 39 miles
Transcutaneous VNS to Treat Pediatric IBD Northwell Health Recruiting N/A
30
Trial Size
39.43 39 miles
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Forest Laboratories Recruiting
3
Trial Phase
1100
Trial Size
40.11 40 miles
EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures Beth Israel Deaconess Medical Center Recruiting N/A
200
Trial Size
40.11 40 miles
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia Merit Medical Systems, Inc. Recruiting
3
Trial Phase
186
Trial Size
40.11 40 miles
Hematology Biobank : Invitro Study of Blood Disorders Albert Einstein College of Medicine of Yeshiva University Recruiting N/A
1000
Trial Size
40.11 40 miles
Neurocognitive Effects of Opiate Agonist Treatment Albert Einstein College of Medicine of Yeshiva University Recruiting
4
Trial Phase
160
Trial Size
40.11 40 miles
Intravenous Gammaglobulin for Sickle Cell Pain Crises Albert Einstein College of Medicine of Yeshiva University Recruiting
1
Trial Phase
94
Trial Size
40.11 40 miles
Virtual Temporal Bone Surgery: Defining and Translating Metrics Nationwide Children's Hospital Recruiting
1
Trial Phase
170
Trial Size
40.11 40 miles
Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
3
Trial Phase
320
Trial Size
40.11 40 miles
Molecular-Guided Therapy for Childhood Cancer Spectrum Health Hospitals Recruiting N/A
56
Trial Size
40.11 40 miles
Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer CytRx Recruiting
2
Trial Phase
132
Trial Size
40.11 40 miles
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection Duke University Recruiting
2
Trial Phase
500
Trial Size
40.11 40 miles
Metformin in Children With Relapsed or Refractory Solid Tumors H. Lee Moffitt Cancer Center and Research Institute Recruiting
1
Trial Phase
25
Trial Size
40.11 40 miles
New Onset Type 1 Diabetes: Role of Exenatide Albert Einstein College of Medicine of Yeshiva University Recruiting
4
Trial Phase
20
Trial Size
40.11 40 miles
Study of Allogeneic EBV-CTLs in EBV-Associated Lymphomas and Lymphoproliferative Disorders Atara Biotherapeutics Available N/A
0
Trial Size
40.11 40 miles
ATA129 for Allogeneic Hematopoietic Cell Transplant Subjects With EBV-PTLD After Failure of Rituximab Atara Biotherapeutics Recruiting
3
Trial Phase
33
Trial Size
40.11 40 miles
ATA129 for Solid Organ Transplant Subjects With EBV-PTLD After Failure of Rituximab or Rituximab and Chemotherapy Atara Biotherapeutics Recruiting
3
Trial Phase
66
Trial Size
40.11 40 miles
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder Avanir Pharmaceuticals Recruiting
2
Trial Phase
150
Trial Size
40.11 40 miles
A Study of MACI in Patients Aged 10 to <17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee Vericel Corporation Recruiting
3
Trial Phase
45
Trial Size
40.11 40 miles
Phase I Study of Fractionated Stereotactic Radiation Therapy Albert Einstein College of Medicine, Inc. Recruiting
1
Trial Phase
43
Trial Size
40.11 40 miles
Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment Columbia University Recruiting N/A
30
Trial Size
40.11 40 miles
Adapting and Expanding the Asthma-Educator App Montefiore Medical Center Recruiting N/A
130
Trial Size
40.11 40 miles
Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease Albert Einstein College of Medicine of Yeshiva University Recruiting N/A
30
Trial Size
40.13 40 miles
Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions AIDS Malignancy Clinical Trials Consortium Recruiting N/A
80
Trial Size
40.13 40 miles
Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer National Cancer Institute (NCI) Recruiting
1
Trial Phase
58
Trial Size
40.13 40 miles
Triciribine Phosphate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer Albert Einstein College of Medicine of Yeshiva University Recruiting
1
Trial Phase
56
Trial Size
40.13 40 miles
Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Montefiore Medical Center Recruiting
1
Trial Phase
18
Trial Size
40.13 40 miles
Lenalidomide and Eltrombopag Olamine in Treating Patients With Symptomatic Anemia in Low or Intermediate Myelodysplastic Syndrome Albert Einstein College of Medicine of Yeshiva University Recruiting
2
Trial Phase
60
Trial Size
40.13 40 miles
Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up) Harvard School of Public Health Recruiting N/A
850
Trial Size
40.13 40 miles
A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures AO Clinical Investigation and Documentation Recruiting N/A
314
Trial Size
40.13 40 miles
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study Vanderbilt University Recruiting
3
Trial Phase
561
Trial Size
40.13 40 miles
Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU Novartis Recruiting
2
Trial Phase
360
Trial Size
40.13 40 miles
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer Montefiore Medical Center Recruiting
2
Trial Phase
25
Trial Size
40.13 40 miles
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer Albert Einstein College of Medicine of Yeshiva University Recruiting
2
Trial Phase
55
Trial Size
40.13 40 miles
Expanded Access Protocol for Therapeutic Use of 177Lu-DOTA0-Tyr3-Octreotate in Midgut Carcinoid Tumors Advanced Accelerator Applications Available N/A
0
Trial Size
40.13 40 miles
Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia Montefiore Medical Center Available N/A
0
Trial Size
40.13 40 miles
Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery National Cancer Institute (NCI) Recruiting
2
Trial Phase
27
Trial Size
40.13 40 miles
Effect of Angulus on Patient-elevation Compliance Angulus, LLC Recruiting N/A
200
Trial Size
40.13 40 miles
Regulation of Endogenous Glucose Production by Central KATP Channels Albert Einstein College of Medicine, Inc. Recruiting
2
Trial Phase
45
Trial Size
40.13 40 miles
Evaluation of Regulation Focused Psychotherapy for Children Yeshiva University Recruiting N/A
40
Trial Size
40.13 40 miles
Program Refinements to Optimize Model Impact and Scalability Based on Evidence City University of New York, School of Public Health Recruiting N/A
594
Trial Size
40.13 40 miles
Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer Albert Einstein College of Medicine Recruiting
2
Trial Phase
25
Trial Size
40.13 40 miles
ATHN 8: PUPs Matter Study American Thrombosis and Hemostasis Network Recruiting N/A
250
Trial Size
40.20 40 miles
Vaccination Efficacy With Metformin in Older Adults UConn Health Recruiting
1
Trial Phase
40
Trial Size
40.20 40 miles
The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study North Shore Long Island Jewish Health System Recruiting N/A
80
Trial Size
40.53 41 miles
A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia Massachusetts General Hospital Recruiting
2
Trial Phase
60
Trial Size
40.53 41 miles
Boost rTMS for Auditory Verbal Hallucinations Northwell Health Recruiting N/A
40
Trial Size
40.53 41 miles
Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer Baxalta US Inc. Recruiting
2
Trial Phase
90
Trial Size
40.56 41 miles
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2) Ferring Pharmaceuticals Recruiting
3
Trial Phase
550
Trial Size
41.22 41 miles
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1) Ferring Pharmaceuticals Recruiting
3
Trial Phase
550
Trial Size
41.22 41 miles
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US Bio-Medical Research, Ltd. Recruiting N/A
180
Trial Size
41.35 41 miles
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract Mati Therapeutics Inc. Recruiting
2
Trial Phase
75
Trial Size
41.35 41 miles
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) Urovant Sciences GmbH Recruiting
3
Trial Phase
1088
Trial Size
41.35 41 miles
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin Menlo Therapeutics Inc. Recruiting
2
Trial Phase
200
Trial Size
41.35 41 miles
Brain and Nerve Stimulation for Hand Muscles in Spinal Cord Injury and ALS Bronx VA Medical Center Recruiting N/A
30
Trial Size
41.57 42 miles
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations Mount Sinai School of Medicine Recruiting
1
Trial Phase
45
Trial Size
41.57 42 miles
Bowel Biofeedback in Persons With SCI James J. Peters Veterans Affairs Medical Center Recruiting N/A
50
Trial Size
41.57 42 miles
Cardiovascular Disease Study Department of Veterans Affairs Recruiting N/A
200
Trial Size
41.57 42 miles
CCT for Diabetic Elderly Veterans Department of Veterans Affairs Recruiting N/A
400
Trial Size
41.57 42 miles
Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI James J. Peters Veterans Affairs Medical Center Recruiting
0
Trial Phase
10
Trial Size
41.57 42 miles
Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury James J. Peters Veterans Affairs Medical Center Recruiting
4
Trial Phase
65
Trial Size
41.57 42 miles
Pilot Study of Open Label, Intranasal Ketamine for Suicidal Ideation in Veterans Bronx Veterans Medical Research Foundation, Inc Recruiting
1
Trial Phase
15
Trial Size
41.57 42 miles
EMG Triggered Closed-Loop Stimulation for Spinal Cord Injury Individuals Bronx VA Medical Center Recruiting N/A
20
Trial Size
41.57 42 miles
Efficacy of Intravenous Lidocaine in the Operative Management of Thyroid Surgery With Intraoperative Nerve Monitoring Bronx-Lebanon Hospital Center Health Care System Recruiting
4
Trial Phase
60
Trial Size
42.40 42 miles
International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder BRC Operations Pty. Ltd. Recruiting
4
Trial Phase
1344
Trial Size
43.10 43 miles
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Reata Pharmaceuticals, Inc. Recruiting
2
Trial Phase
210
Trial Size
43.87 44 miles
A Study Evaluating ABI-H0731 as Adjunctive Therapy in HBeAg-positive Patients With Chronic Hepatitis B Assembly Biosciences Recruiting
2
Trial Phase
45
Trial Size
43.87 44 miles
A Long-term Extension Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients Assembly Biosciences Recruiting
2
Trial Phase
100
Trial Size
43.87 44 miles
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment National Cancer Institute (NCI) Recruiting
3
Trial Phase
224
Trial Size
43.87 44 miles
The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse Pop Medical Solutions Recruiting N/A
60
Trial Size
44.42 44 miles
Assessment of Bullying in Children New York City Health and Hospitals Corporation Recruiting N/A
80
Trial Size
44.46 44 miles
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors Center for International Blood and Marrow Transplant Research Recruiting
3
Trial Phase
35000
Trial Size
44.48 44 miles
Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis University of Pittsburgh Recruiting
2
Trial Phase
40
Trial Size
44.63 45 miles
Progressive Keratoconus or Ectasia Treatment Plan Columbia University Available N/A
0
Trial Size
44.63 45 miles
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
3
Trial Phase
800
Trial Size
44.63 45 miles
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma Academic Myeloma Consortium Recruiting
1
Trial Phase
117
Trial Size
44.63 45 miles
Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation Mayo Clinic Recruiting N/A
160
Trial Size
44.63 45 miles
A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis Academic Myeloma Consortium Recruiting
1
Trial Phase
42
Trial Size
44.63 45 miles
Stem Cell Transplant in Sickle Cell Disease and Thalassemia Columbia University Recruiting
2
Trial Phase
70
Trial Size
44.63 45 miles
Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease Alkeus Pharmaceuticals, Inc. Recruiting
2
Trial Phase
50
Trial Size
44.63 45 miles
Bone Mass and Strength After Kidney Transplantation Columbia University Recruiting
2
Trial Phase
100
Trial Size
44.63 45 miles
Interactive, Health Literacy Promoting Text Messages and HPV Vaccine Completion In Minority Adolescents Columbia University Recruiting N/A
956
Trial Size
44.63 45 miles
Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors Bristol-Myers Squibb Recruiting
1
Trial Phase
195
Trial Size
44.63 45 miles
VX15/2503 Treatment for Huntington's Disease Vaccinex Inc. Recruiting
2
Trial Phase
84
Trial Size
44.63 45 miles
Vitamin D Supplementation in Multiple Sclerosis Johns Hopkins University Recruiting
3
Trial Phase
172
Trial Size
44.63 45 miles
Early Behavioral Intervention for Preterm Infants Columbia University Recruiting
1
Trial Phase
80
Trial Size
44.63 45 miles
Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation CareDx Recruiting N/A
300
Trial Size
44.63 45 miles
JOURNEYâ„¢ II CR Total Knee System Smith & Nephew, Inc. Recruiting N/A
170
Trial Size
44.63 45 miles
Dominantly Inherited Alzheimer Network (DIAN) Washington University School of Medicine Recruiting N/A
400
Trial Size
44.63 45 miles
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma Therapeutic Advances in Childhood Leukemia Consortium Recruiting
1
Trial Phase
30
Trial Size
44.63 45 miles
A Study to Assess the Efficacy and Safety of IONIS-SMN Rx in Patients With Later-onset Spinal Muscular Atrophy Isis Pharmaceuticals Recruiting
3
Trial Phase
117
Trial Size
44.63 45 miles
Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease Columbia University Recruiting
2
Trial Phase
36
Trial Size
44.63 45 miles
Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression Mayo Clinic Recruiting
3
Trial Phase
10
Trial Size
44.63 45 miles
Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging New York State Psychiatric Institute Recruiting
4
Trial Phase
25
Trial Size
44.63 45 miles
Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE) Boston Scientific Corporation Recruiting
2
Trial Phase
100
Trial Size
44.63 45 miles
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors Children's Oncology Group Recruiting
1
Trial Phase
51
Trial Size
44.63 45 miles
Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease University of Miami Recruiting N/A
175
Trial Size
44.63 45 miles
Excision Followed by Radiofrequency Ablation for Breast Cancer University of Arkansas Recruiting N/A
300
Trial Size
44.63 45 miles
Prospective Study of Hormone Levels After Bariatric Surgery Columbia University Recruiting N/A
240
Trial Size
44.63 45 miles
Changes in Insulin Sensitivity After Weight Loss Columbia University Recruiting N/A
110
Trial Size
44.63 45 miles
Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients. New York State Psychiatric Institute Recruiting
2
Trial Phase
150
Trial Size
44.63 45 miles
RHYTHM (Formerly Escape II Myocardium) Columbia University Recruiting N/A
25
Trial Size
44.63 45 miles
Early Feasibility Study of the Edwards Tricuspid Transcatheter Repair System Edwards Lifesciences Recruiting N/A
15
Trial Size
44.63 45 miles
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy Columbia University Recruiting
2
Trial Phase
20
Trial Size
44.63 45 miles
Rituximab and Belimumab for Lupus Nephritis National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
2
Trial Phase
40
Trial Size
44.63 45 miles
IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements University of Minnesota - Clinical and Translational Science Institute Recruiting N/A
30
Trial Size
44.63 45 miles
An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread Bristol-Myers Squibb Recruiting
1
Trial Phase
300
Trial Size
44.63 45 miles
ATTR Expanded Access Program (EAP) by Ionis Ionis Pharmaceuticals, Inc. Available N/A
0
Trial Size
44.63 45 miles
Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer Genentech, Inc. Recruiting
1
Trial Phase
55
Trial Size
44.63 45 miles
Neural and Mobile Assessment OF Behavior Change Among Problem Drinkers New York State Psychiatric Institute Recruiting N/A
150
Trial Size
44.63 45 miles
Coordinating Center: Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy Massachusetts General Hospital Recruiting N/A
500
Trial Size
44.63 45 miles
Efficacy and Safety of AAV2-REP1 for the Treatment of Choroideremia Nightstar Therapeutics Recruiting
3
Trial Phase
140
Trial Size
44.63 45 miles
Rolandic Epilepsy Genomewide Association International Study King's College London Recruiting N/A
3000
Trial Size
44.63 45 miles
Bethanechol Prior to Pancreatic Surgery Columbia University Recruiting
1
Trial Phase
18
Trial Size
44.63 45 miles
Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease Columbia University Recruiting N/A
36
Trial Size
44.63 45 miles
Treatment of Periodontitis With Er:YAG Laser Columbia University Recruiting N/A
24
Trial Size
44.63 45 miles
Lipografting Versus Steroid Injections for Treatment of Carpal Tunnel Syndrome Columbia University Recruiting
1
Trial Phase
100
Trial Size
44.63 45 miles
Brain Imaging in Bipolar Depression to Understand the Role of Inflammation in Antidepressant Treatment New York State Psychiatric Institute Recruiting
1
Trial Phase
3
Trial Size
44.63 45 miles
Health in Individuals With a Spinal Cord Injury: a Prospective Study Columbia University Recruiting N/A
50
Trial Size
44.63 45 miles
Imaging Inflammation in Alzheimer's Disease With 11C-ER176 Columbia University Recruiting
1
Trial Phase
50
Trial Size
44.63 45 miles
Medial Branch Radiofrequency Ablation and Lumbar Multifidi Columbia University Recruiting N/A
12
Trial Size
44.63 45 miles
Platelet-rich Plasma in the Sacroiliac Joint Columbia University Recruiting N/A
40
Trial Size
44.63 45 miles
Upright Back Posture Device Study Columbia University Recruiting N/A
45
Trial Size
44.63 45 miles
Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With Pyridoxamine Columbia University Recruiting N/A
52
Trial Size
44.63 45 miles
A Study for the Production of a Personalized Neoantigen Cancer Vaccine Gritstone Oncology, Inc. Recruiting N/A
40
Trial Size
44.63 45 miles
COPD Exacerbation Blood and Urine Biomarkers Study Columbia University Recruiting N/A
60
Trial Size
44.63 45 miles
18F-DCFPyL PET/CT in Men With Prostate Cancer Columbia University Recruiting
2
Trial Phase
300
Trial Size
44.63 45 miles
Hip Hop Stroke: Statewide Dissemination of a School-based Public Stroke Education Intervention Columbia University Recruiting N/A
4700
Trial Size
44.63 45 miles
Amyotrophic Lateral Sclerosis (ALS) Families Project Columbia University Recruiting N/A
60
Trial Size
44.63 45 miles
Mechanical Environment Pregnancy With Short Cervix Columbia University Recruiting N/A
36
Trial Size
44.63 45 miles
Reducing Teen Pregnancy in the Emergency Department Columbia University Recruiting
2
Trial Phase
250
Trial Size
44.63 45 miles
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer Southwest Oncology Group Recruiting N/A
1050
Trial Size
44.63 45 miles
Effect of Hip Hop Nutrition-Math Curriculum Columbia University Recruiting N/A
560
Trial Size
44.63 45 miles
OLIF25™ /OLIF51™ Study Medtronic Spinal and Biologics Recruiting N/A
500
Trial Size
44.76 45 miles
A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label AVEO Pharmaceuticals, Inc. Recruiting
2
Trial Phase
86
Trial Size
44.87 45 miles
AGN-241751 in the Treatment of Major Depressive Disorder Allergan Recruiting
2
Trial Phase
250
Trial Size
44.87 45 miles
Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently Memorial Sloan Kettering Cancer Center Recruiting N/A
60
Trial Size
45.38 45 miles
Safety and Efficacy of Autologous Concentrated Bone Marrow Aspirate for Critical Limb Ischemia - Continued Access Biomet, Inc. Available N/A
0
Trial Size
45.49 45 miles
An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse Acorda Therapeutics Recruiting
1
Trial Phase
30
Trial Size
45.49 45 miles
Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration NJ Retina (Retina Associates of New Jersey) Recruiting
1
Trial Phase
88
Trial Size
45.49 45 miles
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers Holy Name Medical Center, Inc. Recruiting N/A
30
Trial Size
45.49 45 miles
Ablation of Unresectable Locally Advanced Pancreatic Cancer With Nanoknife Irreversible Electroporation (IRE) System: Response and Tolerability Holy Name Medical Center, Inc. Recruiting N/A
30
Trial Size
45.49 45 miles
APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults Advanced Plasma Therapies Inc Recruiting N/A
80
Trial Size
45.90 46 miles
Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis Formation Biologics Recruiting
1
Trial Phase
24
Trial Size
45.90 46 miles
Feasibility and Acceptability of a Physical Activity Behavior Change Intervention for Parkinson's Disease Teachers College, Columbia University Recruiting
1
Trial Phase
12
Trial Size
46.13 46 miles
The Impact of Dosing Parameters on Motor Skill Acquisition and Retention in Bilateral Cerebral Palsy (BCP) Shriners Hospitals for Children Recruiting N/A
48
Trial Size
46.13 46 miles
Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis Akros Pharma Inc. Recruiting
2
Trial Phase
85
Trial Size
46.15 46 miles
Assessing Response to Albuterol in Bronchiolitis Connecticut Children's Medical Center Recruiting N/A
25
Trial Size
46.59 47 miles
The Genetics of Respiratory Failure in Bronchiolitis Connecticut Children's Medical Center Recruiting N/A
146
Trial Size
46.59 47 miles
Timing of Pessary Care Hartford Hospital Recruiting N/A
126
Trial Size
46.59 47 miles
Improving Medication Adherence in Pediatric Inflammatory Bowel Disease Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
3
Trial Phase
194
Trial Size
46.59 47 miles
Protein in Feeding Strategies to Accelerate Muscle Recovery From ACL Reconstruction University of Connecticut Recruiting N/A
20
Trial Size
46.59 47 miles
Study Evaluate the PK Profile of Dalbavancin in Hospitalized Infants and Neonates Patients With Known or Suspected Bacterial Infection Allergan Recruiting
1
Trial Phase
12
Trial Size
46.59 47 miles
Feasibility and Acceptability of the Hailie Monitoring System in Children With Persistent Asthma Connecticut Children's Medical Center Recruiting N/A
100
Trial Size
46.59 47 miles
Rx for Success: RCT of an App for Dialogic Reading Training Children's Hospital Medical Center, Cincinnati Recruiting N/A
248
Trial Size
46.59 47 miles
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke North Shore Long Island Jewish Health System Recruiting N/A
75
Trial Size
46.61 47 miles
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma Celgene Corporation Available N/A
0
Trial Size
46.68 47 miles
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Dana-Farber Cancer Institute Recruiting
3
Trial Phase
660
Trial Size
46.68 47 miles
Double Cord Versus Haploidentical (BMT CTN 1101) Medical College of Wisconsin Recruiting
3
Trial Phase
410
Trial Size
46.68 47 miles
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli Kaye, Keith, M.D., M.P.H. Recruiting
3
Trial Phase
444
Trial Size
46.68 47 miles
A Pilot Study of Deep Brain Stimulation to the Lateral Habenulae in Treatment-Resistant Depression Mount Sinai School of Medicine Recruiting
1
Trial Phase
6
Trial Size
46.68 47 miles
Longitudinal Study of Urea Cycle Disorders Office of Rare Diseases (ORD) Recruiting
2
Trial Phase
1100
Trial Size
46.68 47 miles
Research Tissue Bank Myeloproliferative Disorders-Research Consortium Recruiting N/A
400
Trial Size
46.68 47 miles
Genetic Testing to Understand and Address Renal Disease Disparities Mount Sinai School of Medicine Recruiting N/A
2050
Trial Size
46.68 47 miles
Improving Self-Management in Head and Neck Cancer Mount Sinai School of Medicine Recruiting N/A
132
Trial Size
46.68 47 miles
CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients Mount Sinai School of Medicine Recruiting N/A
400
Trial Size
46.68 47 miles
Biomarkers of Liver Fibrosis Mount Sinai School of Medicine Recruiting N/A
40
Trial Size
46.68 47 miles
Changes in the Brain as Borderline Patients Learn to Regulate Their Emotions Mount Sinai School of Medicine Recruiting N/A
288
Trial Size
46.68 47 miles
A Study of LY2801653 in Advanced Cancer Eli Lilly and Company Recruiting
1
Trial Phase
190
Trial Size
46.68 47 miles
Ruxolitinib in Combination With Autotransplant Mount Sinai School of Medicine Recruiting N/A
10
Trial Size
46.68 47 miles
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension Arbor Pharmaceuticals, Inc. Recruiting
3
Trial Phase
260
Trial Size
46.68 47 miles
Short-term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia Children's Research Institute Recruiting
2
Trial Phase
144
Trial Size
46.68 47 miles
Reversing Ticagrelor's Effects With Fresh Platelets Mount Sinai School of Medicine Recruiting
4
Trial Phase
40
Trial Size
46.68 47 miles
Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial) Mount Sinai School of Medicine Recruiting
1
Trial Phase
58
Trial Size
46.68 47 miles
Intrathecal Hydromorphone for Pain Control After Cesarean Section Mount Sinai School of Medicine Recruiting
2
Trial Phase
50
Trial Size
46.68 47 miles
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Undergoing Surgery National Cancer Institute (NCI) Recruiting N/A
45
Trial Size
46.68 47 miles
Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia Mount Sinai School of Medicine Recruiting
1
Trial Phase
30
Trial Size
46.68 47 miles
Adult Liver Transplant Enhanced Care Mount Sinai School of Medicine Recruiting N/A
8
Trial Size
46.68 47 miles
Correlative Biomarker Study in Patients With Myeloproliferative Disorders Myeloproliferative Disorders-Research Consortium Recruiting N/A
860
Trial Size
46.68 47 miles
Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma Mount Sinai School of Medicine Recruiting
2
Trial Phase
35
Trial Size
46.68 47 miles
Manuka Honey for Wound Care Mount Sinai School of Medicine Recruiting
4
Trial Phase
60
Trial Size
46.68 47 miles
Self-injection and Self-management Mount Sinai School of Medicine Recruiting N/A
60
Trial Size
46.68 47 miles
Study to Treat Major Depressive Disorder With a New Medication Icahn School of Medicine at Mount Sinai Recruiting
2
Trial Phase
48
Trial Size
46.68 47 miles
RecoverLINK Technology Pilot for HF Patients RecoverLINK Recruiting N/A
63
Trial Size
46.68 47 miles
ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization Icahn School of Medicine at Mount Sinai Recruiting N/A
20
Trial Size
46.68 47 miles
Eliminating Hepatitis C Virus Icahn School of Medicine at Mount Sinai Recruiting N/A
700
Trial Size
46.68 47 miles
Assessment of Portal Hypertension With Multiparametric MRI Icahn School of Medicine at Mount Sinai Recruiting N/A
186
Trial Size
46.68 47 miles
Online Emotion Regulation Group Intervention Icahn School of Medicine at Mount Sinai Recruiting N/A
104
Trial Size
46.68 47 miles
Break the Cycle: Prevention for Reducing Initiation Into Injection Drug Use Icahn School of Medicine at Mount Sinai Recruiting N/A
400
Trial Size
46.68 47 miles
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment Icahn School of Medicine at Mount Sinai Recruiting
2
Trial Phase
20
Trial Size
46.68 47 miles
CivaSheet With Radical Prostatectomy & Adjuvant External Beam Radiation Icahn School of Medicine at Mount Sinai Recruiting N/A
12
Trial Size
46.68 47 miles
Intraoperative Video Laryngoscopy as Adjunct for Nerve Monitoring Icahn School of Medicine at Mount Sinai Recruiting N/A
125
Trial Size
46.68 47 miles
Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease Intralytix, Inc. Recruiting
1
Trial Phase
30
Trial Size
46.68 47 miles
Noom Coach for Bariatric Health Noom Inc. Recruiting N/A
200
Trial Size
46.68 47 miles
Care.Coach Avatars for Improvement of Outcomes in Hospitalized Elders, Including Mitigation of Falls and Delirium: a Multi-Site Clinical Study care.coach corporation Recruiting
2
Trial Phase
7000
Trial Size
46.95 47 miles
Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo St. Luke's-Roosevelt Hospital Center Recruiting N/A
1500
Trial Size
47.27 47 miles
Biology of Juvenile Myoclonic Epilepsy King's College London Recruiting N/A
1000
Trial Size
47.27 47 miles
Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (CLARITY-2) ACADIA Pharmaceuticals Inc. Recruiting
3
Trial Phase
280
Trial Size
47.36 47 miles
Selecting a Favorable KIR Donor in Unrelated HCT for AML Masonic Cancer Center, University of Minnesota Recruiting N/A
800
Trial Size
47.45 47 miles
Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients Novartis Recruiting
1
Trial Phase
100
Trial Size
47.45 47 miles
Clinical Trial to Evaluate Blister Graft Utilizing a Novel Harvesting Device for Treatment of Venous Leg Ulcers SerenaGroup, Inc. Recruiting
4
Trial Phase
194
Trial Size
47.45 47 miles
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma University of Chicago Recruiting
1
Trial Phase
92
Trial Size
47.45 47 miles
Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients Fred Hutchinson Cancer Research Center Recruiting N/A
1000
Trial Size
47.45 47 miles
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC Novartis Available N/A
0
Trial Size
47.45 47 miles
A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple Myeloma Seattle Genetics, Inc. Recruiting
1
Trial Phase
75
Trial Size
47.45 47 miles
VelaShape III & UltraShape Power for Thigh Circumference Reduction Syneron Medical Recruiting N/A
40
Trial Size
47.45 47 miles
Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes Hackensack University Medical Center Recruiting N/A
50
Trial Size
47.45 47 miles
Robot Assisted Virtual Rehabilitation for the Hand Post Stroke (RAVR) New Jersey Institute of Technology Recruiting N/A
120
Trial Size
47.45 47 miles
Gut Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer Hackensack University Medical Center Recruiting N/A
49
Trial Size
47.45 47 miles
AroMatherapy for Blood and Marrow Transplant PatIENTs (AMBIENT) Hackensack University Medical Center Recruiting N/A
200
Trial Size
47.45 47 miles
Brentuximab Vedotin and Nivolumab in Treating Participants With Early Stage Classic Hodgkin Lymphoma City of Hope Medical Center Recruiting
2
Trial Phase
264
Trial Size
47.45 47 miles
Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD) Pharmacyclics LLC. Recruiting
1
Trial Phase
44
Trial Size
47.45 47 miles
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant Emory University Recruiting
2
Trial Phase
27
Trial Size
47.45 47 miles
Trial of Combination of Elotuzumab and Lenalidomide +/- Dexamethasone in High-Risk Smoldering Multiple Myeloma Dana-Farber Cancer Institute Recruiting
2
Trial Phase
82
Trial Size
47.54 48 miles
Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck North Shore Long Island Jewish Health System Recruiting
1
Trial Phase
21
Trial Size
47.64 48 miles
Evaluation of Efficacy and Safety of Votiva for Vaginal Rejuvenation Walden, Jennifer L., M.D.,P.L.L.C. Recruiting N/A
50
Trial Size
47.64 48 miles
Translating Telephonic Diabetes Self-management Support to Primary Care Practice Albert Einstein College of Medicine of Yeshiva University Recruiting N/A
875
Trial Size
48.13 48 miles
Oral TRK Inhibitor LOXO-101 for Treatment of Advanced Adult Solid Tumors Loxo Oncology, Inc. Recruiting
1
Trial Phase
108
Trial Size
48.13 48 miles
The Genetics of Severe Asthma in Children Connecticut Children's Medical Center Recruiting N/A
558
Trial Size
48.25 48 miles
What is the Impact of the Presence of a Support Person on Informed Consent Hartford Hospital Recruiting N/A
74
Trial Size
48.25 48 miles
Sildenafil in US Heart Failure Patients (SilHF-US) Hartford Hospital Recruiting
3
Trial Phase
25
Trial Size
48.27 48 miles
Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia Shionogi Inc. Recruiting
1
Trial Phase
18
Trial Size
48.27 48 miles
The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI) Hospital for Special Surgery, New York Recruiting
4
Trial Phase
106
Trial Size
48.34 48 miles
Humanitarian Use of AVANTA Orthopaedics Proximal Interphalangeal Joint Hospital for Special Surgery, New York Available N/A
0
Trial Size
48.34 48 miles
BBD Longitudinal Study of Osteogenesis Imperfecta Baylor College of Medicine Recruiting N/A
1000
Trial Size
48.34 48 miles
Intrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy Patients Weill Medical College of Cornell University Recruiting N/A
40
Trial Size
48.34 48 miles
LEGION Hinge Safety and Efficacy Study Smith & Nephew, Inc. Recruiting N/A
45
Trial Size
48.34 48 miles
Scleroderma Treatment With Autologous Transplant (STAT) Study Fred Hutchinson Cancer Research Center Recruiting
2
Trial Phase
30
Trial Size
48.34 48 miles
Intraperitoneal Radioimmunotherapy With 131I-8H9 for Patients With Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum Memorial Sloan-Kettering Cancer Center Recruiting
1
Trial Phase
45
Trial Size
48.34 48 miles
Pilot Study of Velcade® in IgA Nephropathy The Rogosin Institute Recruiting
4
Trial Phase
15
Trial Size
48.34 48 miles
Effect of Testosterone Treatment on Embryo Quality Center for Human Reproduction Recruiting
1
Trial Phase
180
Trial Size
48.34 48 miles
Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD) Astellas Pharma Inc Available N/A
0
Trial Size
48.34 48 miles
Using Addiction Comprehensive Health Enhancement Support System (ACHESS) in an Alcoholic Liver Disease Population New York Presbyterian Hospital Recruiting N/A
30
Trial Size
48.34 48 miles
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
27
Trial Size
48.34 48 miles
ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue Evaluation Precision Biopsy, Inc. Recruiting N/A
325
Trial Size
48.34 48 miles
Geriatric Communication Skills Training Program for Oncology Clinicians Memorial Sloan Kettering Cancer Center Recruiting N/A
108
Trial Size
48.34 48 miles
Prospectively Randomized Study of Intra-ovarian Injections of Autologous PRP in Women With Primary Ovarian Insufficiency Center for Human Reproduction Recruiting N/A
40
Trial Size
48.34 48 miles
Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients Memorial Sloan Kettering Cancer Center Recruiting N/A
75
Trial Size
48.34 48 miles
GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting
1
Trial Phase
36
Trial Size
48.34 48 miles
Post Market Clinical Follow-up Study of the REDAPT Monolithic Sleeveless Stem and Acetabular Components Devices Used for Hip Replacement Surgery. Smith & Nephew, Inc. Recruiting N/A
100
Trial Size
48.34 48 miles
RCT of Mobile Apps & FitBit v. Usual Care Weill Medical College of Cornell University Recruiting N/A
135
Trial Size
48.34 48 miles
The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
130
Trial Size
48.34 48 miles
Fetal Genome Profiling Via Trophoblast Cells Weill Medical College of Cornell University Recruiting N/A
70
Trial Size
48.34 48 miles
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis Hospital for Special Surgery, New York Recruiting
2
Trial Phase
30
Trial Size
48.34 48 miles
Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients Memorial Sloan Kettering Cancer Center Recruiting N/A
270
Trial Size
48.34 48 miles
Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies Memorial Sloan Kettering Cancer Center Recruiting N/A
20
Trial Size
48.34 48 miles
A Study of a Device Used to Take Pictures of Skin Blood Flow Memorial Sloan Kettering Cancer Center Recruiting N/A
8
Trial Size
48.34 48 miles
Evaluation of 3D Machine-vision Image Guided Surgery Spine Navigation 7D Surgical Inc. Recruiting N/A
130
Trial Size
48.34 48 miles
Use of Eylea for the Treatment of an Optic Nerve Hemangioma Vitreous -Retina- Macula Consultants of New York Available N/A
0
Trial Size
49.05 49 miles
Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease Berg Pharma,LLC Recruiting
1
Trial Phase
18
Trial Size
49.05 49 miles
A Single-Center Open-Label Study of 1064 nm Nd:YAG for Nonablative Skin Rejuvenation Cutera Inc. Recruiting N/A
15
Trial Size
49.05 49 miles
Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis Weill Medical College of Cornell University Recruiting N/A
15
Trial Size
49.05 49 miles
Comparative User Experiences With BD Nano™ PRO 4mm x 32G Extra Thin Wall Pen Needle vs Three Commercially Available Pen Needles Becton, Dickinson and Company Recruiting N/A
146
Trial Size
49.24 49 miles
Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream Drug Delivery Solutions Ltd. (part of MC2 Therapeutics) Recruiting
1
Trial Phase
30
Trial Size
49.24 49 miles
Ruxolitinib in Estrogen Receptor Positive Breast Cancer Abramson Cancer Center of the University of Pennsylvania Recruiting
2
Trial Phase
30
Trial Size
49.40 49 miles
METformin With a Cargohydrate Restricted Diet in Combination With Platinum Based Chemotherapy in Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer Beth Israel Medical Center Recruiting
2
Trial Phase
60
Trial Size
49.49 49 miles
Determine the Clinical Advantage of IV vs PO Acetaminophen Icahn School of Medicine at Mount Sinai Recruiting
4
Trial Phase
120
Trial Size
49.49 49 miles
Efficacy Between Serratus Plane Block And Local Infiltration In Vats Icahn School of Medicine at Mount Sinai Recruiting
4
Trial Phase
100
Trial Size
49.49 49 miles
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU Icahn School of Medicine at Mount Sinai Recruiting N/A
178
Trial Size
49.49 49 miles
Clinical Evaluation of CelluTite Treatment InMode MD Ltd. Recruiting N/A
40
Trial Size
49.49 49 miles
Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis Tisch Multiple Sclerosis Research Center of New York Available N/A
0
Trial Size
49.49 49 miles
3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN) CDA Research Group, Inc. Recruiting
1
Trial Phase
30
Trial Size
49.96 50 miles
Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module Heidelberg Engineering GmbH Recruiting N/A
60
Trial Size
49.96 50 miles
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection Gilead Sciences Recruiting
3
Trial Phase
100
Trial Size
50.08 50 miles
Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial New York University School of Medicine Recruiting N/A
284
Trial Size
50.08 50 miles
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones Mayo Clinic Recruiting N/A
150
Trial Size
50.08 50 miles
A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study Apollo Endosurgery, Inc. Recruiting N/A
325
Trial Size
50.08 50 miles
Study of Suture Repair of Torn Meniscus in the Knee Ceterix Orthopaedics, Inc. Recruiting N/A
30
Trial Size
50.08 50 miles
Obstructive Sleep Apnea in World Trade Center Responders University of Medicine and Dentistry New Jersey Recruiting N/A
440
Trial Size
50.08 50 miles
A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors GlaxoSmithKline Recruiting
1
Trial Phase
200
Trial Size
50.08 50 miles
GSK1120212 Rollover Study GlaxoSmithKline Recruiting
2
Trial Phase
250
Trial Size
50.08 50 miles
Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI New York University School of Medicine Recruiting N/A
30
Trial Size
50.08 50 miles
Low-profile visualized intraluminal support -HUD New York University School of Medicine Available N/A
0
Trial Size
50.08 50 miles
The Poweroff Sleep Study New York University School of Medicine Recruiting N/A
65
Trial Size
50.08 50 miles
Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer New York University School of Medicine Recruiting N/A
60
Trial Size
50.08 50 miles
Efficacy of a Gluten-free Diet in Difficult to Manage Nephrotic Syndrome: Utility of Plasma Zonulin Levels as a Predictive Biomarker New York University School of Medicine Recruiting N/A
40
Trial Size
50.08 50 miles
A Phase 2 Study of CX-8998 in Adolescents and Young Adults With Generalized Epileptic Syndromes With Absence Seizures Cavion LLC Recruiting
2
Trial Phase
30
Trial Size
50.08 50 miles
LaseMD System for the Treatment of Melasma LUTRONIC Corporation Recruiting N/A
10
Trial Size
50.08 50 miles
Using Rapid Cycle Randomized Controlled Trials to Increase Patient Engagement in the Annual Well Visits Program New York University School of Medicine Recruiting N/A
12000
Trial Size
50.08 50 miles

View Legend


Listings display only those clinical trials that have locations in the USA. Distances calculated are an approximation only.

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.